| |
| |
| Exchange: |
N/A |
| Security
Type: |
Common |
| Shares
Out: |
2,970,000 |
| Market
Cap: |
1.11(M) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$0.3751 - $0.3751 |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile OncoSec Medical is a immuno-oncology company focused on designing, developing and commercializing intra-tumoral DNA-based therapeutics to stimulate and to guide anti-tumor immune responses for the treatment of cancers. Co.'s main technology platform ImmunoPulse® is a drug-device therapeutic modality platform comprised of proprietary intratumoral electroporation (EP) delivery devices (the OncoSec Medical System (OMS) EP Device) and a proprietary DNA plasmid. The OMS EP Device is designed to deliver plasmid DNA-encoded drugs into a solid tumor and promote an immunological response against cancer. Co.'s main product candidate is a DNA-encoded interleukin-12 called tavokinogene telseplasmid.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
0 |
0 |
0 |
607 |
| Total Sell Value |
$0 |
$0 |
$0 |
$362 |
| Total People Sold |
0 |
0 |
0 |
1 |
| Total Sell Transactions |
0 |
0 |
0 |
3 |
| End Date |
2024-02-22 |
2023-11-21 |
2023-05-23 |
2022-05-23 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Demesa James M |
Director |
– • – |
2018-11-20 |
4 |
B |
$0.80 |
$5,600 |
D/D |
7,000 |
21,001 |
2.39 |
- |
|
| Demesa James M |
Director |
– • – |
2018-11-07 |
4 |
B |
$0.91 |
$1,365 |
D/D |
1,500 |
14,001 |
2.31 |
- |
|
| O'connor Daniel |
CEO & President |
• • – |
2018-11-07 |
4 |
B |
$0.91 |
$9,100 |
D/D |
10,000 |
26,667 |
2.81 |
- |
|
| Bonstein Sara |
CFO/COO |
• – – |
2018-09-16 |
4 |
D |
$1.58 |
$24,340 |
D/D |
(15,405) |
474,110 |
|
- |
|
| Bonstein Sara |
CFO/COO |
• – – |
2018-07-16 |
4 |
D |
$1.34 |
$181,550 |
D/D |
(135,485) |
489,515 |
|
- |
|
| Bonstein Sara |
CFO/COO |
• – – |
2018-07-16 |
4 |
A |
$0.00 |
$0 |
D/D |
625,000 |
625,000 |
|
- |
|
| Dhillon Punit |
Director |
– • – |
2018-07-05 |
4 |
S |
$1.31 |
$60,070 |
D/D |
(45,785) |
485,262 |
|
- |
|
| Slansky Richard B |
Chief Financial Officer |
• – – |
2018-07-05 |
4 |
S |
$1.31 |
$8,823 |
D/D |
(6,725) |
270,016 |
|
- |
|
| Dhillon Avtar S |
Director |
– • – |
2018-07-05 |
4 |
S |
$1.31 |
$4,067 |
D/D |
(3,100) |
143,427 |
|
- |
|
| Dhillon Punit |
Director |
– • – |
2018-06-29 |
4 |
S |
$1.38 |
$7,453 |
D/D |
(5,401) |
531,047 |
|
- |
|
| Slansky Richard B |
Chief Financial Officer |
• – – |
2018-06-29 |
4 |
S |
$1.38 |
$3,340 |
D/D |
(2,420) |
276,741 |
|
- |
|
| Dhillon Avtar S |
Director |
– • – |
2018-06-29 |
4 |
S |
$1.38 |
$1,471 |
D/D |
(1,066) |
146,527 |
|
- |
|
| Dhillon Punit |
Director |
– • – |
2018-06-28 |
4 |
S |
$1.40 |
$11,043 |
D/D |
(7,882) |
536,448 |
|
- |
|
| Slansky Richard B |
Chief Financial Officer |
• – – |
2018-06-28 |
4 |
S |
$1.40 |
$4,948 |
D/D |
(3,532) |
279,161 |
|
- |
|
| Dhillon Avtar S |
Director |
– • – |
2018-06-28 |
4 |
S |
$1.40 |
$2,180 |
D/D |
(1,556) |
147,593 |
|
- |
|
| Dhillon Punit |
Director |
– • – |
2018-06-27 |
4 |
S |
$1.37 |
$24,018 |
D/D |
(17,480) |
544,330 |
|
- |
|
| Slansky Richard B |
Chief Financial Officer |
• – – |
2018-06-27 |
4 |
S |
$1.37 |
$10,761 |
D/D |
(7,832) |
282,693 |
|
- |
|
| Dhillon Avtar S |
Director |
– • – |
2018-06-27 |
4 |
S |
$1.37 |
$4,742 |
D/D |
(3,451) |
149,149 |
|
- |
|
| Dhillon Punit |
Director |
– • – |
2018-06-26 |
4 |
S |
$1.40 |
$33,300 |
D/D |
(23,820) |
561,810 |
|
- |
|
| Slansky Richard B |
Chief Financial Officer |
• – – |
2018-06-26 |
4 |
S |
$1.40 |
$14,921 |
D/D |
(10,673) |
290,525 |
|
- |
|
| Dhillon Avtar S |
Director |
– • – |
2018-06-26 |
4 |
S |
$1.40 |
$6,575 |
D/D |
(4,703) |
152,600 |
|
- |
|
| Dhillon Punit |
Director |
– • – |
2018-06-25 |
4 |
S |
$1.41 |
$1,435 |
D/D |
(1,021) |
585,630 |
|
- |
|
| Slansky Richard B |
Chief Financial Officer |
• – – |
2018-06-25 |
4 |
S |
$1.41 |
$643 |
D/D |
(458) |
301,198 |
|
- |
|
| Dhillon Avtar S |
Director |
– • – |
2018-06-25 |
4 |
S |
$1.41 |
$284 |
D/D |
(202) |
157,303 |
|
- |
|
| Dhillon Punit |
Director |
– • – |
2018-06-22 |
4 |
S |
$1.42 |
$21,236 |
D/D |
(14,976) |
586,651 |
|
- |
|
121 Records found
|
|
Page 3 of 5 |
|
|
